Physician profile
Adam Fuller
NPI 1699400606
$851.97
in general payments reported to CMS, 2019-2025
18 companies · $654 in 2025
The $654 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $198 · 2025: $654.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $169.35 | 2023 | Descovy |
| Abbvie INC. | $80.35 | 2025 | |
| Antares Pharma, INC. | $73.23 | 2025 | Xyosted |
| Pfizer INC. | $61.70 | 2025 | |
| Janssen Biotech, INC. | $48.21 | 2025 | Erleada |
| Urogen Pharma, INC. | $45.18 | 2025 | |
| Angiodynamics, INC. | $43.95 | 2025 | Nanoknife |
| Boston Scientific Corporation | $40.23 | 2025 | Spaceoar Vue System - 10ml |
| Tolmar, INC. | $37.34 | 2025 | Rubraca, Eligard |
| Pharmaand Gmbh | $37.34 | 2025 | Rubraca |
| Olympus America INC. | $36.56 | 2025 | Uropass |
| Verity Pharmaceuticals INC. | $36.09 | 2025 | Trelstar |
| Bluewind Medical | $32.14 | 2025 | Revi |
| Bayer Healthcare Pharmaceuticals INC. | $29.88 | 2025 | |
| Viiv Healthcare Company | $28.24 | 2023 | Apretude |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $21.71 | 2025 | Cvac Aspiration System |
| Ambu INC. | $16.04 | 2025 | |
| Abc Home Medical Supply, INC. | $14.43 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.